ZIGLIM M2 (Glimepiride (2mg) + Metformin (500mg))

Ziglim-M 2 Tablet falls under the category of medications classified as anti-diabetic agents. This specific formulation combines two active components, making it effective in managing type 2 diabetes mellitus in adult patients. Its primary function is to assist in regulating blood sugar levels for individuals diagnosed with diabetes. For optimal results, it is recommended to take Ziglim-M 2 Tablet in conjunction with food. Adhering to a consistent schedule, taking the medication at the same time each day, will enhance its effectiveness. The appropriate dosage will be determined by your healthcare provider, who may adjust it over time based on your response to the treatment and your blood glucose measurements. It is essential to continue using this medication, even if you feel well or believe your blood sugar is under control. Discontinuing Ziglim-M 2 Tablet without consulting your healthcare provider could lead to elevated blood sugar levels, which may increase the risk of serious complications such as kidney damage, vision loss, nerve issues, and limb loss. Additionally, this medication is part of a broader diabetes management plan that includes maintaining a nutritious diet, engaging in regular physical activity, and achieving weight loss goals as recommended by your physician. Lifestyle choices play a crucial role in managing diabetes effectively. The most frequently encountered adverse effect of Ziglim-M 2 Tablet is the occurrence of low blood sugar levels (hypoglycemia). It is important to be aware of the symptoms associated with low blood sugar, which can include sweating, dizziness, headaches, and tremors, and to know how to respond. To minimize the risk of hypoglycemia, it is advisable to consume meals regularly and keep a quick source of glucose, such as sweets or fruit juice, readily available. The consumption of alcohol should be avoided as it can heighten the likelihood of experiencing low blood sugar levels. Additional side effects that may arise from taking this medication include alterations in taste, nausea, diarrhea, abdominal discomfort, headaches, and respiratory infections affecting the upper tract. Some individuals may experience weight gain while using Ziglim-M 2 Tablet. It is contraindicated for individuals with type 1 diabetes mellitus, diabetic ketoacidosis (elevated acid levels in the blood), or significant renal or hepatic impairment. Prior to initiating treatment, patients should inform their healthcare provider of any history of cardiovascular conditions, as this medication may not be appropriate. Pregnant or nursing individuals should also seek medical advice before using this medication. Routine monitoring of blood sugar levels is essential, and your doctor may recommend blood tests to evaluate blood cell counts and liver function regularly.